Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Endothelial dysfunction: molecular mechanisms and clinical implications
2024 Standout
2 intermediate papers

Works of Abdullah Shehab being referenced

Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE)
2018
Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates
2016

Author Peers

Author Last Decade Papers Cites
Abdullah Shehab 212 54 65 80 30 388
Mostafa Q. Alshamiri 248 41 58 39 24 431
David K Cundiff 157 44 45 40 25 415
Martin Lindgren 251 42 31 62 35 415
Yacob G. Tedla 318 32 30 35 29 451
Joanna Jaroch 228 32 25 82 42 368
P. Iaria 264 70 50 65 26 429
Swetha Palli 84 96 75 81 36 449
Jeremy Sayer 264 88 58 33 32 417
Anders Holt 190 31 33 34 40 369
Robert Sawicki 113 102 28 76 34 370

All Works

Loading papers...

Rankless by CCL
2026